Document is current
Any future updates will be listed below
-
Authors
Ehrlich, Aliza T. https://orcid.org/0000-0001-7507-1100
Semache, Meriem
Couvineau, Pierre
Wojcik, Stefan
Kobayashi, Hiroyuki
Thelen, Marcus
Gross, Florence
Hogue, Mireille
Le Gouill, Christian
Darcq, Emmanuel
Bouvier, Michel
Kieffer, Brigitte L.
-
Funding
Funding for this research was provided by:
Réseau Québécois de Recherche sur les Médicaments
Region Alsace/Biovalley
FEDER
National Institute on Drug Abuse (DA05010)
Canadian Institute for Health Research (MOP11215, FDN148431)
- License Information
-
More Information
Article History
Received: 22 April 2021
Accepted: 17 September 2021
First Online: 28 September 2021
Declarations
:
: All experimental procedures were performed in accordance with the guidelines of the Canadian Council of Animal Care, and all animal procedures were approved by the McGill University/Douglas Hospital Animal Care Committee.
: Not applicable.
: The authors declare no potential conflict of interest. Some of the BRET-based biosensors used in this study are the object of patent protection and were licensed to Domain Therapeutics; all BRET-based biosensors can be obtained for non-commercial use through regular academic material transfer agreements.
